Can ertapenem be administered intramuscularly, and what is the recommended duration of therapy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Ertapenem Intramuscular Administration and Duration

Yes, ertapenem can be administered intramuscularly for up to 7 days, after which intravenous administration should be used if continued therapy is needed. 1

Route of Administration

Ertapenem may be given via two routes 1:

  • Intravenous (IV) infusion: Up to 14 days
  • Intramuscular (IM) injection: Up to 7 days maximum

The IM route serves as an alternative to IV administration only for infections where intramuscular therapy is appropriate. 1 The FDA label explicitly states that IM administration is limited to 7 days, while IV infusion can continue for up to 14 days. 1

Dosing Regimen

Adults and Pediatric Patients ≥13 Years

  • Dose: 1 gram once daily (IV or IM) 1
  • The bioavailability of IM ertapenem is 92% compared to IV administration 2

Pediatric Patients 3 Months to 12 Years

  • Dose: 15 mg/kg twice daily (not to exceed 1 g/day) 3, 1

Duration by Indication

The total treatment duration varies by infection type 1:

  • Complicated intra-abdominal infections: 5-14 days
  • Complicated skin and skin structure infections (including diabetic foot infections without osteomyelitis): 7-14 days (up to 28 days for diabetic foot infections)
  • Community-acquired pneumonia: 10-14 days
  • Complicated urinary tract infections/pyelonephritis: 10-14 days
  • Acute pelvic infections: 3-10 days

Important Clinical Considerations

Preparation and Administration

  • Must be reconstituted with lidocaine for IM injection 4
  • Do not use diluents containing dextrose 1
  • Do not mix or co-infuse with other medications 1
  • When given IV, infuse over 30 minutes 1

Tolerability

IM ertapenem reconstituted in lidocaine is generally well tolerated, with local injection site symptoms (primarily tenderness and pain) occurring in approximately 36% of patients, though moderate to severe symptoms are rare (1.1% in clinical trials). 4 The tolerability profile is comparable to IM ceftriaxone. 4, 5

Renal Impairment

For adult patients with creatinine clearance ≤30 mL/min/1.73 m², reduce the dose to 500 mg daily. 1 If ertapenem is given within 6 hours before hemodialysis, administer a supplementary 150 mg dose after the dialysis session. 1

Common Pitfall

The 7-day limit for IM administration is absolute per FDA labeling. 1 If therapy beyond 7 days is required, transition to IV administration. This limitation exists despite ertapenem not accumulating with repeated daily IM dosing over 7 days. 2

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.